Top Funds / PERCEPTIVE ADVISORS LLC


Joseph Edelman

2015Q3 Portfolio

SEC 13F Filing

Position #Shares $Value % # vs. 2015Q2 $ vs. 2015Q2
AMICUS THERAPEUTICS, INC. 14,439,444 $175,633,000 14.03% No Change -$28,685,000
NEUROCRINE BIOSCIENCES INC 2,942,967 $117,101,000 9.35% -341,500 -$39,765,000
Sarepta Therapeutics, Inc. 2,784,928 $89,424,000 7.14% -24,600 +$3,930,000
Retrophin, Inc. 2,647,080 $53,629,000 4.28% -173,795 -$38,021,000
Tesaro Inc 981,759 $39,368,000 3.14% +146,400 -$9,743,000
Global Blood Therapeutics, Inc. 921,800 $38,863,000 3.10% New +$38,863,000
Dyax Corp 1,646,315 $31,428,000 2.51% -140,000 -$15,909,000
NEVRO CORP 606,811 $28,150,000 2.25% -192,148 -$14,794,000
GW PHARMACEUTICALS PLC ADS PUT 300,000 $27,411,000 2.19% New +$27,411,000
PTC THERAPEUTICS, INC. PUT 1,005,000 $26,834,000 2.14% New +$26,834,000
VERSARTIS INC 2,317,954 $26,726,000 2.13% +996,554 +$6,614,000
ISHARES RUSSELL 2000 RUSSELL 2000 ETF PUT 200,000 $21,840,000 1.74% New +$21,840,000
Xencor Inc 1,754,784 $21,461,000 1.71% -130,000 -$19,948,000
ACELRX PHARMACEUTICALS INC 6,264,060 $19,105,000 1.53% -310,000 -$8,769,000
Relypsa Inc 987,942 $18,287,000 1.46% -151,200 -$19,407,000
LA JOLLA PHARMACEUTICAL CO PAR $.0001 2 654,515 $18,189,000 1.45% +401,600 +$11,990,000
REGENXBIO Inc. 779,213 $17,166,000 1.37% New +$17,166,000
SPDR S&P MIDCAP 400 ETF TRUST S&P BIOTECH PUT 275,000 $17,119,000 1.37% +125,000 -$20,717,000
LION BIOTECHNOLOGIES INC 2,955,456 $17,023,000 1.36% +195,863 -$8,282,000
Cephalon Inc 1,931,600 $16,959,000 1.35% -36,000 -$12,732,000
CEMPRA INC 582,500 $16,217,000 1.30% +10,000 -$3,454,000
Pfenex Inc. 971,043 $14,575,000 1.16% -39,834 -$5,036,000
uniQure N.V. 690,269 $14,116,000 1.13% +40,000 -$3,441,000
PROSHARES ULTRA S & P500 P ULT S&P 500 PUT 200,000 $11,120,000 0.89% +150,000 +$7,893,000
CAPITAL SENIOR LIVING CORP 553,600 $11,100,000 0.89% -86,900 -$4,592,000